Similar to p50−/− mice, myeloid-specific deletion of PGE2 receptor EP4 or its pharmacological inhibition has led to a significant reduction of genetically-induced intestinal tumorigenesis (ApcMin mice), in association with increased frequency of M1-anti-tumor macrophages [74]. Here, CD40 is linked to neoplasm.